News

Parkinson’s is a progressive neurological condition driven by the loss of dopamine-producing neurons, which causes tremors, ...
Cell therapy development for Parkinson’s disease has been a marathon. Two new papers represent an important step forward.
Two independent clinical trials demonstrate the safety of stem cell therapies for Parkinson's disease. The papers, published ...
The phase I clinical trials showed stem cell transplants for Parkinson’s disease appear to be safe and might restore dopamine-producing brain cells.
Reacting to the findings of the trials, which have been published in the journal Nature, Claire Bale, associate director of ...
Two studies published in Nature found stem-cell derived products can not only be safely transplanted into the brain, but also ...
Induced pluripotent stem cells are being tested to treat blindness, paralysis, Parkinson’s disease and more. Approvals might ...
A stem cell–based therapy initially developed at Memorial Sloan Kettering Cancer Center (MSK) may lead to a new treatment for advanced Parkinson's disease, according to results from a phase 1 clinical ...
they could provide an easily accessible source of neural stem cells that could be used in the future to treat diseases such as Parkinson's disease, spinal cord injury and other neurodegenerative ...
Florey researchers have engineered a way to fool the immune system into accepting neural grafts as part of the body, rather ...
A Japanese group said Thursday that it succeeded in improving symptoms of Parkinson's disease patients with nerve cells ...